TE_38974
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluSz |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | TTTY14 |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 0.23 |
| Counts of samples | TCGA_tumor:386; TCGA_normal:32; GTEx:1836 |
| TSS | chrY(-):18850800 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38974.1 | TTTY14 | Annoated | Non-coding | Non-coding | chrY(-):18804827,18804847,18813616,18813743,18819355,18819460,18819554,18819786,18828585,18828719,18830436,18830639,18833002,18833103,18833756,18833918,18836320,18836409,18839182,18839313,18839932,18840137,18849225,18849284,18850677,18850801 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
